Concourse Financial Group Securities’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 4058 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 5264 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5249 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 5280 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 5284 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5228 |
|
|
2023
Q3 | – | Sell |
-1
| Closed | -$3 | – | 5150 |
|
|
2023
Q2 | $3 | Hold |
1
| – | – | ﹤0.01% | 2326 |
|
|
2023
Q1 | $6 | Buy |
+1
| New | +$6 | ﹤0.01% | 2358 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 4878 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 4689 |
|
|
2022
Q2 | – | Sell |
-25
| Closed | -$1K | – | 4712 |
|
|
2022
Q1 | $1K | Sell |
25
-18
| -42% | -$720 | ﹤0.01% | 2104 |
|
|
2021
Q4 | $3K | Hold |
43
| – | – | ﹤0.01% | 2135 |
|
|
2021
Q3 | $4K | Sell |
43
-250
| -85% | -$23.3K | ﹤0.01% | 2118 |
|
|
2021
Q2 | $33K | Buy |
293
+43
| +17% | +$4.84K | ﹤0.01% | 1462 |
|
|
2021
Q1 | $28K | Hold |
250
| – | – | ﹤0.01% | 1448 |
|
|
2020
Q4 | $27K | Buy |
250
+220
| +733% | +$23.8K | ﹤0.01% | 1352 |
|
|
2020
Q3 | $4K | Buy |
30
+13
| +76% | +$1.73K | ﹤0.01% | 1859 |
|
|
2020
Q2 | $5K | Sell |
17
-66
| -80% | -$19.4K | ﹤0.01% | 1673 |
|
|
2020
Q1 | $7K | Buy |
+83
| New | +$7K | ﹤0.01% | 1554 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3893 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3656 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3906 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3850 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3733 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3392 |
|